SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesA MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2Differential regulation of sentrinized proteins by a novel sentrin-specific proteaseBovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 proteinStabilization and activation of p53 by the coactivator protein TAFII31Cloning and characterization of LUN, a novel ring finger protein that is highly expressed in lung and specifically binds to a palindromic sequenceCommon properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modificationNuclear import/export of hRPF1/Nedd4 regulates the ubiquitin-dependent degradation of its nuclear substratesNMR structure of the N-terminal domain of SUMO ligase PIAS1 and its interaction with tumor suppressor p53 and A/T-rich DNA oligomersThe interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaBSmall ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor αCUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasomeSUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activitySumoylated SnoN represses transcription in a promoter-specific mannerPositive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modificationNuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modificationEnzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcriptionChromatin-bound IκBα regulates a subset of polycomb target genes in differentiation and cancerRegulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteinsSUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processingMDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signalingNegative modulation of androgen receptor transcriptional activity by DaxxSUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavageIn silico structural and functional characterization of the RSUME splice variantsRegulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifierLens epithelium-derived growth factor deSumoylation by Sumo-specific protease-1 regulates its transcriptional activation of small heat shock protein and the cellular responseAssociation with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruptionProteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodiesAssociation of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9Modification with SUMO. A role in transcriptional regulationTranscription factor Sp3 is silenced through SUMO modification by PIAS1The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylaseDesumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin.Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modificationsThe CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1Role for SUMO modification in facilitating transcriptional repression by BKLF.
P2860
Q21296830-072D0050-63D2-40AF-838E-D97E5BCC55A8Q22009372-4059BCEB-9DEA-4A03-99DA-D8B52DF19234Q22011173-3DB0D70A-4166-409F-B7DC-8870D83B5295Q22254410-24563FE0-7039-4FDD-95CA-CD4F6B7C657CQ24291008-06254883-2264-4D37-A666-C762D61A2EB1Q24291022-09CB99D5-A9AA-4489-801C-A6EB96B9EC31Q24291154-754C236A-7744-430C-B7F3-A167DD51773EQ24291211-8CA67133-0DD1-41B8-8FEB-EA8E7E5B72C9Q24292722-16BE81F6-5B1B-41DB-9337-0369FD4062B7Q24295552-50EAD3EE-AFFE-4052-8F02-E85EE6A1E4E5Q24297577-21AABC1D-9E68-4DF8-B829-D3BD6D9CE6FDQ24299412-95C878A0-36FC-4D7D-B330-C2089B71ED5AQ24300888-C90CF508-27D1-45C6-BD4B-52EF6E962E60Q24302417-8DF7DDEB-A446-435E-B6F5-D2107E1B2694Q24304218-148CBF37-8E52-4690-9CFD-80DFAAA260FEQ24304276-13AEE3A6-09EE-4DD4-92DF-0D3A5DC802E4Q24305181-A0F8B9E0-A02A-4D14-B04E-6B3BFBEC06C7Q24306717-391C6F07-0835-4A04-98AB-977D54E4F275Q24307883-7796991D-015C-4935-B6D0-79F7382E68A7Q24309409-8DF8DA7C-9782-4592-BB99-25A70FD702BBQ24312155-2570E275-F995-49DA-A760-FCD1802E5528Q24316163-C902C286-3A64-418C-80F2-ED38671CA055Q24318233-D467FC69-7C64-4014-A35C-2D6AFC09D044Q24320238-DDD5E957-C252-4B55-A837-7E12200F3739Q24323152-B0D9BEDD-6F7F-4895-BDF4-B42306501548Q24329223-26FE1D79-491F-4ABA-9611-A4AD5347F9FAQ24339376-3C09666F-F8B6-4B0D-B862-2D1154446A4BQ24519076-07C5F60A-DE2F-47F6-9541-411CF48E1822Q24527246-D28EEA54-75AF-4893-9883-408CD3ED176EQ24529191-0AD92871-EB9D-41F8-9F38-8365C517AB90Q24529499-C37A0192-68F9-4484-BFF9-37DC8EA80FF0Q24532208-46E89C21-8DF3-4600-B241-4467B2DCC0A3Q24534589-1B3B72CE-A845-4A66-BED1-8FDB6A436D5AQ24534887-D3B7BDD8-22BD-40A1-9EE1-E7567CDB90CAQ24534918-95C9DBDC-FED2-45BF-BBBE-1FB449CC0738Q24537390-E5EC6AC9-F74F-4EEC-8713-15C87257F782Q24540313-CEA4CC1C-E2AD-4905-86A4-F83E300AFAFBQ24545952-D33E9958-7BD4-4C52-B46C-8421B8683598Q24551152-385E3BB2-948E-47F4-8CC8-714ABA15E385Q24556900-587B0E40-363E-43B9-BD26-968B3D4C29D3
P2860
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@ast
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@en
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@nl
type
label
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@ast
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@en
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@nl
prefLabel
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@ast
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@en
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@nl
P2093
P3181
P1433
P1476
SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
@en
P2093
J M Desterro
M S Rodriguez
P3181
P356
10.1016/S1097-2765(00)80133-1
P407
P577
1998-08-01T00:00:00Z